Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (28 ops.)
Latest filing published 12 Jan 2026 for Zymeworks Inc., €182k.
Filing timeline
BuySaleJeffrey T. L. Smith
Insider track record
Disclosed buys
0
Disclosed sells
28
Signal history
Jeffrey T. L. Smith: trading record in brief
Jeffrey T. L. Smith discloses dealings in 2 companies, chiefly Alder Biopharmaceuticals Inc and Zymeworks Inc. Over a trading history stretching from 3 June 2016 to 12 January 2026, the count stands at 55 filings.
The open-market record consists of 28 sales worth €2.8M, with no purchase. The rest of the record consists of 2 share grants and 23 option exercises. 2026 to date brings no purchases and 2 sales.
On 12 January 2026 came the latest disclosure, an open-market sale for €182k in Zymeworks Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey T. L. Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations55 total
9,310 shares@ US$22.6731.9% of flowCommon StockSEC:0001193125-26-010865:1
17,666 shares0Common StockSEC:0001193125-26-010865:0
10,538 shares@ US$25.1039.8% of flowCommon StockSEC:0001193125-26-003102:1
20,000 shares0Common StockSEC:0001193125-26-003102:0
11,110 shares@ US$14.9228.3% of flowCommon StockSEC:0000950170-25-002490:1
20,000 shares0Common StockSEC:0000950170-25-002490:0
16,230 shares0Common StockSEC:0001209191-19-053919:0
21,502 shares@ US$18.0021.3% of flowCommon StockSEC:0001209191-19-053919:1
22,727 shares@ US$4.465.7% of flowCommon StockSEC:0001209191-19-050079:0
10,001 shares@ US$3.471.9% of flowCommon StockSEC:0001209191-19-050079:1
32,728 shares@ US$18.4433.7% of flowCommon StockSEC:0001209191-19-050079:2
9,288 shares0Common StockSEC:0001209191-19-026035:0
4,847 shares@ US$13.733.0% of flowCommon StockSEC:0001209191-19-026035:1
5,044 shares@ US$0.990.2% of flowCommon StockSEC:0001209191-18-061036:0
5,044 shares@ US$13.84343.1% of flowCommon StockSEC:0001209191-18-061036:1
5,040 shares@ US$0.990.2% of flowCommon StockSEC:0001209191-18-057264:0
5,040 shares@ US$13.423.0% of flowCommon StockSEC:0001209191-18-057264:1
5,040 shares@ US$0.990.2% of flowCommon StockSEC:0001209191-18-054090:0
3,040 shares@ US$15.25832.0% of flowCommon StockSEC:0001209191-18-054090:1
2,000 shares@ US$15.97211.4% of flowCommon StockSEC:0001209191-18-054090:2
5,040 shares@ US$0.990.2% of flowCommon StockSEC:0001209191-18-049877:0
5,040 shares@ US$17.99583.9% of flowCommon StockSEC:0001209191-18-049877:1
5,040 shares@ US$0.990.2% of flowCommon StockSEC:0001209191-18-045042:0
4,060 shares@ US$19.48783.4% of flowCommon StockSEC:0001209191-18-045042:1
980 shares@ US$19.76380.8% of flowCommon StockSEC:0001209191-18-045042:2
25 of 55 declarations
